# Acumen Pharmaceuticals, Inc.: Form SC 13D/A, filed Jul 25, 2023

- Company: [Acumen Pharmaceuticals, Inc.](/companies/abos.md) (CIK 1576885)
- Form: SC 13D/A
- Filed: 2023-07-25
- Accepted by EDGAR: Jul 25, 2023, 16:31 ET
- Period: not reported
- Accession: 0001104659-23-083859
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1576885/000110465923083859/tm2322013d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1576885/000110465923083859/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1576885/000110465923083859/tm2322013d1_sc13da.htm

Filed Jul 25, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-083859. Last ingested by Listed: Nov 5, 2026, 16:24 ET. No prices; not investment advice.